Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Adolesc Med ; 12(1): 95-104, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11224025

ABSTRACT

Chest pain invokes serious concern in adolescents, their families, and their primary care physicians. These concerns are fueled by media reports of sudden death in high-profile athletes and the high incidence of ischemic heart disease in our society. However, chest pain in this age group is usually benign and a careful clinical evaluation including a detailed history and physical examination may guide the clinician in reaching a diagnosis, obtaining the appropriate diagnostic studies, and making the proper referrals to specialists.


Subject(s)
Chest Pain/etiology , Musculoskeletal Diseases/complications , Adolescent , Arrhythmias, Cardiac/complications , Chest Pain/diagnosis , Diagnosis, Differential , Heart Defects, Congenital/complications , Humans , Primary Health Care/methods
2.
Am J Med Genet ; 75(1): 88-94, 1998 Jan 06.
Article in English | MEDLINE | ID: mdl-9450864

ABSTRACT

We observed a girl with an interrupted, left inferior vena cava with hemiazygous continuation, bilateral superior venae cavae, heart defects, and sacral agenesis. She had macrostomia and bilateral ear tags and pits, as in oculoauriculovertebral defect. Maternal diabetes was present. The combination, which we call OAV-heterotaxia complex, supports the view that some cases of oculoauriculovertebral defect may be part of a midline field defect of blastogenesis.


Subject(s)
Goldenhar Syndrome/pathology , Vena Cava, Inferior/abnormalities , Vena Cava, Superior/abnormalities , Female , Goldenhar Syndrome/diagnostic imaging , Goldenhar Syndrome/genetics , Heart Defects, Congenital/diagnostic imaging , Heart Defects, Congenital/genetics , Heart Defects, Congenital/pathology , Humans , Infant, Newborn , Pregnancy , Radiography , Vena Cava, Inferior/diagnostic imaging , Vena Cava, Superior/diagnostic imaging
3.
Disabil Rehabil ; 18(8): 402-7, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8842625

ABSTRACT

While accessibility has increasingly become a concern in today's society, the implementation of this concern has failed to address many issues. This paper discusses the components of exclusivity, safety, and reasonability in accessibility. Common problems in the implementation of these factors are addressed. These elements in both design for accessibility and evaluation of accessibility, constitute the principle of accommodation in accessibility. The application of ergonomic principles to improve the accommodation of accessibility is proposed.


Subject(s)
Architectural Accessibility , Disabled Persons , Ergonomics , Anthropometry , Humans , Self-Help Devices , Wheelchairs
4.
Bus Health ; 11(6): 56, 55, 1993 May.
Article in English | MEDLINE | ID: mdl-10126113
5.
Arthritis Rheum ; 29(4): 501-7, 1986 Apr.
Article in English | MEDLINE | ID: mdl-3486663

ABSTRACT

A sensitive in vitro bioassay for the alpha-interferon induction of lupus-type inclusions (LI) has been established with the human B lymphoblastoid cell line, Daudi. Sera from 11 patients with systemic lupus erythematosus (SLE) were evaluated with this assay. LI induction by these sera increased in proportion to their antiviral activity on Madin-Darby bovine kidney (MDBK) cells. Two of these sera did not induce LI; they showed no antiviral activity on the MDBK cell assay. Clinically and serologically, their donors were in remission. Two sera induced the formation of LI that exceeded the maximum frequencies obtained with 3 alpha-interferon preparations. These sera had the greatest antiviral activities, and their donors had the greatest disease activities. Antisera to alpha-interferons prevented the induction of LI with the pure and homogeneous recombinant human leukocyte interferon, IFLrA, and SLE sera. Together, these results provide evidence that the alpha-interferon endogenous to SLE patients has a great ability to induce LI, and the SLE serum induction of LI corresponds well to the patient's disease activity.


Subject(s)
Inclusion Bodies, Viral/metabolism , Lupus Erythematosus, Systemic/blood , Animals , Antiviral Agents/pharmacology , Antiviral Agents/physiology , B-Lymphocytes , Burkitt Lymphoma/pathology , Cattle , Cell Line , Humans , Interferon Type I/pharmacology , Kidney , Lupus Erythematosus, Systemic/pathology
6.
Healthc Financ Manage ; 38(10): 60-6, 1984 Oct.
Article in English | MEDLINE | ID: mdl-10315615

ABSTRACT

Under PPS an effective utilization management system is essential and the implementation of such systems presents a new challenge for hospital managers. An effective utilization management system must have the following characteristics: a process for establishing expected resource levels for each DRG; the ability to assign a working DRG at admission; a review schedule for each DRG; a method of identifying consistent patterns of high utilization; a focused review plan which targets selected DRG and physicians; a method of predicting the clinical treatment requirements of each patient; a review process which evaluates the need for continued hospitalization and identifies the reasons for any misutilization, and a feedback process which modifies the focused review plan on an ongoing basis. By operating a utilization management system with these attributes on a concurrent basis, a hospital will achieve the monitoring and control over its resources so critical under PPS. Hospitals that are able to successfully implement a utilization management system will have accomplished one of the essential components necessary to respond to PPS.


Subject(s)
Health Services Misuse , Health Services , Hospitals/statistics & numerical data , Prospective Payment System/economics , Reimbursement Mechanisms/economics , Utilization Review , Ancillary Services, Hospital/statistics & numerical data , Diagnosis-Related Groups , Efficiency , Humans , Length of Stay/economics , United States
8.
J Interferon Res ; 4(3): 335-45, 1984.
Article in English | MEDLINE | ID: mdl-6092490

ABSTRACT

Raji and Daudi are human B lymphoblastoid cell lines that readily form lupus inclusions (LIs; TRS) when grown in medium supplemented with leukocyte-, or fibroblast-derived interferon (IFN-alpha, -beta, respectively). WISH, MDBK, and GM2504 are three cell lines commonly used to measure antiviral activities. None of them form LIs in their antiviral response to alpha or immune (gamma)IFN. This distinguishes between the abilities of a cell to develop an antiviral state and to form LIs in response to IFN. Human (Hu) lymphoblastoid IFN and the two pure and homogeneous recombinant human IFN-alpha proteins IFLrA and IFLrD induce LIs in Raji cells and Daudi cells. In Daudi, a simultaneous inhibition of cell growth occurs. When compared by antiviral activities, IFLrA inhibits the growth of Daudi cells more, while IFLrD induces the greater frequency of LIs. According to molecular concentration, IFLrA and IFLrD at 133 X 10(-13) M induce LIs in Daudi cells to their maximum frequency. Growth inhibition for these same cell samples is also at maximum for IFLrA, but only 25% of maximum for IFLrD. Our results with Raji and Daudi cells provide evidence against a cause-and-effect relationship between these two biologic responses to IFN by Daudi cells. They also provide evidence for distinct, but interacting, intracellular pathways. This phenomenon is a new explanation for some of the biologic diversity shown for the HuIFNs-alpha.


Subject(s)
B-Lymphocytes/drug effects , Inclusion Bodies/drug effects , Interferon Type I/pharmacology , Lupus Erythematosus, Systemic/pathology , B-Lymphocytes/immunology , B-Lymphocytes/ultrastructure , Cell Division/drug effects , Cell Line , Humans , Viral Interference
SELECTION OF CITATIONS
SEARCH DETAIL
...